Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of NMRA will rise by +25.77% over the next 2 Weeks and hit $4.39 by Friday, March 13, 2026. In that time frame, NMRA's share price is expected to range between $4.12 and $4.69.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Mar 13, 2026 | 4.00 | 4.31 | 4.60 |
| Mar 12, 2026 | 4.02 | 4.30 | 4.60 |
| Mar 11, 2026 | 3.90 | 4.20 | 4.51 |
| Mar 10, 2026 | 3.88 | 4.16 | 4.46 |
| Mar 9, 2026 | 3.68 | 3.99 | 4.27 |
| Mar 6, 2026 | 3.61 | 3.90 | 4.19 |
| Mar 5, 2026 | 3.61 | 3.89 | 4.19 |
| Mar 4, 2026 | 3.49 | 3.78 | 4.09 |
| Mar 3, 2026 | 3.47 | 3.75 | 4.05 |
| Mar 2, 2026 | 3.29 | 3.57 | 3.87 |
NMRA shares fell -8.31% in Monday, March 2, 2026's trading session, dropping from a previous close of $3.49 to move at $3.20. The stock demonstrated notable intraday movement (see NMRA's key stats for a full breakdown), fluctuating between $2.76 and $3.27, a +18.48% trading range. While recent weeks have seen some volatility, NMRA has managed to secure a -9.60% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 1.96M shares changing hands, 1.42M more than the previous session. This amounted to $6.29M in total market activity.
Will NMRA Continue Its Upward Trend?
According to analyst ratings and projections for NMRA, Neumora Therapeutics, Inc. Common Stock shares are anticipated to increase by +30.39%, potentially reaching $4.60 per share by March 13, 2026. Short-term technical indicators for NMRA currently suggest a bullish sentiment. Despite this, the stock appears to be in a state of indecision, having seen 15 positive and 15 negative trading days over the last 30 sessions. Based on the NMRA stock forecast, now is a good time to buy NMRA stock because its current trading price is -25.76% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on NMRA covering social and institutional perspectives.
NMRA Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into NMRA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 53.14% to 61.00%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 58.56%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 52.71%, maintains a neutral outlook for the long term. Insights into NMRA's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Neumora Therapeutics Common Stock Short-Term Forecasts
NMRA Forecast For Next 5 Days
Our algorithm anticipates Neumora Therapeutics Common Stock (NMRA) stock could hit $4.00 by Mar 09, 2026. This represents a +25.09% fall from today's price, following a -15.77% change over the past five days.
NMRA Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Neumora Therapeutics, Inc. Common Stock (NMRA) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $3.97, which would mean a +24.06% increase from the current price of $3.20. Projections for this period range from a high of $5.10 to a low of $2.82.
NMRA Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Neumora Therapeutics Common Stock's price over the next three months point to a rise. NMRA stock is expected to peak at $8.63 on Mar 13, 2026 before potentially dipping to $2.94 on Apr 08, 2026. On average, NMRA is likely to trade around $5.05 in the coming 90 days.
Neumora Therapeutics Common Stock Stock Forecast 2025
Based on our predictive models, Neumora Therapeutics Common Stock (NMRA) is expected to trade between $2.51 and $22.84 throughout 2026. This would result in an average price of $8.05, potentially offering investors a +151.56% return from current levels.
Neumora Therapeutics, Inc. Common Stock Monthly Forecast 2026–2027
March 2026
According to our latest forecast models, Neumora Therapeutics, Inc. Common Stock (NMRA) is positioned to show a strong performance in March 2026. The price is predicted to move between $4.16 and $8.63, settling at an average of $7.20. This could translate to a +125.00% gain.
April 2026
Based on current market signals, Neumora Therapeutics, Inc. Common Stock is projected to trend april 2026. We forecast a trading range from $2.94 to $4.51, with a likely average price of $3.68. Investors could expect a potential return of +15.00%.
May 2026
Our predictive algorithms indicate Neumora Therapeutics, Inc. Common Stock stock may see a shift in May 2026. The expected range spans $3.25–$5.52, with an average target of $4.40. This represents a positive outlook and a possible gain of +37.50%.
June 2026
Analyzing established trends, Neumora Therapeutics, Inc. Common Stock looks set to move in June 2026. Projections place the stock between $2.51 and $5.04, averaging around $3.81. This suggests a +19.06% gain from current levels.
July 2026
Market indicators suggest Neumora Therapeutics, Inc. Common Stock could experience notable changes during July 2026. Prices could fluctuate within $3.77 to $9.36, with a midpoint forecast of $5.63. The stock might deliver a +75.94% gain.
August 2026
Forecasting for August 2026, models estimate that Neumora Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $4.09 and $12.03, averaging $9.74. This signals a positive trajectory with potential returns around +204.37%.
September 2026
According to our latest forecast models, Neumora Therapeutics, Inc. Common Stock (NMRA) is positioned to show a strong performance in September 2026. The price is predicted to move between $3.62 and $11.15, settling at an average of $7.13. This could translate to a +122.81% gain.
October 2026
Based on current market signals, Neumora Therapeutics, Inc. Common Stock is projected to trend october 2026. We forecast a trading range from $6.62 to $14.24, with a likely average price of $12.09. Investors could expect a potential return of +277.81%.
November 2026
Our predictive algorithms indicate Neumora Therapeutics, Inc. Common Stock stock may see a shift in November 2026. The expected range spans $5.20–$14.00, with an average target of $10.89. This represents a positive outlook and a possible gain of +240.31%.
December 2026
Analyzing established trends, Neumora Therapeutics, Inc. Common Stock looks set to move in December 2026. Projections place the stock between $6.16 and $22.84, averaging around $15.68. This suggests a +390.00% gain from current levels.
January 2027
Market indicators suggest Neumora Therapeutics, Inc. Common Stock could experience notable changes during January 2027. Prices could fluctuate within $3.24 to $22.81, with a midpoint forecast of $13.14. The stock might deliver a +310.62% gain.
February 2027
Forecasting for February 2027, models estimate that Neumora Therapeutics, Inc. Common Stock may undergo key fluctuations. If trends hold, the stock might trade between $3.37 and $17.69, averaging $10.51. This signals a positive trajectory with potential returns around +228.44%.
March 2027
According to our latest forecast models, Neumora Therapeutics, Inc. Common Stock (NMRA) is positioned to show a strong performance in March 2027. The price is predicted to move between $5.40 and $19.05, settling at an average of $14.23. This could translate to a +344.69% gain.
NMRA's history of dividends and stock splits also plays a role in long-term investor confidence.